Health care jobs are among the best-paying because, experts say, the high cost of education and training often involves years ...

Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

Confirming the bedrock principle that the antitrust laws are designed to protect competition and not individual competitors, ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The chair of the UK's competition regulator has been removed from his role by the government, amid its push for growth. Marcus Bokkerink, the head of the Competition and Markets Authority (CMA ...

Analyst Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report) and keeping the price target at $91.00. Ryan Zimmerman’s rating is based on a combination of ...

TAIPEI, Taiwan — China's navy has commissioned a new-generation frigate as competition rises with the U.S. and other regional powers, saying the ship will “play a vital role in enhancing the ...